Reaction

Gastrostomy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,517 reports · 38 co-occurring drugs

As of the last recalculation, Gastrostomy appears in 1,517 FAERS reports alongside 38 co-occurring drug terms. The strongest observed disproportionality signal is CENOBAMATE (PRR 23.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Cenobamate	14	23.2	23.3
Brivaracetam	13	20.0	20.0
Lumacaftor And Ivacaftor	12	19.4	19.4
Clobazam	33	18.9	19.0
Cannabidiol	31	18.5	18.6
Vigabatrin	18	17.1	17.2
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	11	15.1	15.1
Emtricitabine And Tenofovir Alafenamide	12	14.6	14.6
Raltegravir	17	14.3	14.3
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	17	13.0	13.0
Carbidopa And Levodopa	40	11.9	11.9
Rotigotine	11	10.5	10.5
Zonisamide	11	10.3	10.3
Cinacalcet Hydrochloride	33	9.9	9.9
Rasagiline Mesylate	8	9.9	9.9
Pancrelipase	27	9.8	9.8
Lacosamide	25	9.4	9.4
Dornase Alfa	13	9.2	9.2
Dolutegravir Sodium	6	9.2	9.2
Amantadine	10	8.9	8.9
Rivastigmine	12	8.8	8.8
Phenobarbital	9	8.6	8.6
Sitagliptin And Metformin Hydrochloride	13	8.3	8.3
Epoprostenol	7	7.4	7.4
Palivizumab	8	7.2	7.2
Tafamidis	6	7.0	7.0
Ivacaftor	4	6.9	6.9
Bosentan	25	6.9	6.9
Atazanavir	7	6.7	6.7
Tobramycin	10	5.7	5.7
Abiraterone Acetate	14	4.7	4.7
Elexacaftor, Tezacaftor, And Ivacaftor	4	4.4	4.4
Valbenazine	8	4.4	4.4
Pimavanserin Tartrate	17	4.3	4.3
Brexpiprazole	5	4.1	4.1
Glecaprevir And Pibrentasvir	3	3.8	3.8
Apalutamide	3	3.5	3.5
Droxidopa	5	3.2	3.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.